NCT00832338 - Trial Using Docetaxel Cytoxan in Breast Cancers With High Recurrence Scores | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

April 30, 2009

Primary Completion Date

October 31, 2015

Study Completion Date

October 31, 2015

Conditions

Breast NeoplasmsBreast CancerCancer of the Breast

Interventions

DRUG

Docetaxel with Cytoxan

Docetaxel 75 mg/m² plus cytoxan 600 mg/m² every 3 weeks for 6 cycles.

DRUG

Dexamethasone

Dexamethasone 4 mg BID PO for 3 consecutive days starting 12-24 hours prior to each dose of docetaxel.

Trial Locations (3)

Grady Memorial Hospital, Atlanta

Emory University Hospital Midtown, Atlanta

Emory University Winship Cancer Institute, Atlanta